ArticleFrontiers in pediatrics2023

Case report: High-dose epoprostenol therapy in pediatric patients with pulmonary hypertension and developmental lung disease.

Yoshie Fukasawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.